Abstract:Even with growing evidence for the involvement of protein oligomeric nano-assemblies in the development of protein misfolding diseases, including Alzheimer's disease (AD) and Parkinson's disease (PD) among others, very limited knowledge exists regarding the molecular mechanisms underlying these processes. This is primarily because the protein aggregates are stabilized by weak interactions that are typically transient in nature and difficult to measure. Therefore, only mixtures of aggregates with different morphologies have been studied thus far; in turn, it is unknown how the aggregation process is initiated and how the growth of oligomers progresses. On the other hand, computational approaches can provide detailed descriptions of how monomers bind to the segments of fibrils. However, these powerful simulations, which provide the structure and dynamics of aggregates at the atomic level, require knowledge of the initial nanoassembly structure; in turn, computational analysis primarily models the elongation process of fibrils. Thus, available computational approaches can be applied to modeling the assembly of oligomers if the structure of the oligomer is known. Herein, we have conducted in silico simulations of Aβ40 monomer assembly in dimers. The simulated structures were validated by comparing Monte Carlo pulling simulations with experimental data from single molecule AFM force spectroscopy enabling us to identify dimers structures rupture of which were in good agreement with the experimental results. One important observation from our long time-scale MD simulations is that the dimer does not have the extended beta-structures observed in fibrils. Rather, it remains largely unstructured and is stabilized by hydrophobic interaction and local hydrogen bonds. The results suggest that the Aβ40 aggregation is a complex process in which the monomer structure depends on the aggregate size.

Multiscale Modeling of Macromolecular Interactions between Tau-Amylin Oligomers and Asymmetric Lipid Nanodomains That Link Alzheimer's and Diabetic Diseases

Molecular Simulations of Amyloid Structures, Toxicity, and Inhibition

Cross-Seeding Interaction Between Β-Amyloid and Human Islet Amyloid Polypeptide.

Energy Landscapes of the Monomer and Dimer of the Alzheimer’s Peptide Aβ(1–28)

Exploring Tau Fibril-Disaggregating and Antioxidating Molecules Binding to Membrane-Bound Amyloid Oligomers Using Machine Learning-Enhanced Docking and Molecular Dynamics

Structural Insights into the Co-Aggregation of Aβ and Tau Amyloid Core Peptides: Revealing Potential Pathological Heterooligomers by Simulations.

Amylin–Aβ Oligomers at Atomic Resolution Using Molecular Dynamics Simulations: a Link Between Type 2 Diabetes and Alzheimer's Disease

Understanding the Twisted Structure of Amyloid Fibrils Via Molecular Simulations

Molecular Dynamics Simulations of Low-Ordered Alzheimer Β-Amyloid Oligomers from Dimer to Hexamer on Self-Assembled Monolayers

Self-Assembly of Full-Size Amyloid Beta 40 Proteins in Dimers

Molecular Dynamics Simulations of Alzheimer Abeta40 Elongation and Lateral Association.

Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer’s Disease, Parkinson’s Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis

Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer's Disease, Parkinson's Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis.

Mechanistic Insights into the Polymorphic Associations and Cross-Seeding of Aβ and hIAPP in the Presence of Histidine Tautomerism: An All-Atom Molecular Dynamic Study

Long-range Regulation of Partially Folded Amyloidogenic Peptides

Dissecting the Molecular Mechanisms of the Co-Aggregation of Aβ40 and Aβ42 Peptides: A REMD Simulation Study

Mechanistic Insights into the Co-Aggregation of Aβ and hIAPP: An All-Atom Molecular Dynamic Study

Molecular Modeling Of Two Distinct Triangular Oligomers In Amyloid Beta-Protein

Recent Studies On Mechanisms Of New Drug Candidates For Alzheimer'S Disease Interacting With Amyloid-Beta Protofibrils Using Molecular Dynamics Simulations

Multivalency drives interactions of alpha-synuclein fibrils with tau

Polymorphism in Alzheimer Aβ Amyloid Organization: Insight into Aβ Aggregation